vascuCAP vs HeartFlow Analysis
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 78/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
These tools are highly comparable, both leveraging AI for non-invasive CT analysis in cardiology to assess cardiovascular health. HeartFlow Analysis uniquely provides Fractional Flow Reserve derived from CT (FFRct) and computational fluid dynamics for functional assessment of coronary artery disease. In contrast, vascuCAP focuses on detailed, histologically-validated plaque quantification and characterization to stratify risk for stroke and heart attack.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Elucid Bioimaging's vascuCAP (now ElucidVivo/PlaqueIQ) is designed for non-invasive CT angiography analysis, quantifying plaque composition and assessing cardiovascular risk to optimize treatment decisions, including risk stratification for stroke and heart attack. HeartFlow Analysis provides a non-invasive solution for diagnosing and managing coronary artery disease (CAD) by creating personalized 3D models of coronary arteries from CT scans and performing Fractional Flow Reserve derived from CT (FFRct) analysis.
vascuCAP offers histologically-validated plaque quantification and characterization, specifically quantifying lipid-rich necrotic core, calcification, non-calcified matrix, and intraplaque hemorrhage. HeartFlow Analysis also provides Plaque Analysis for quantification and characterization, which includes quantifying total plaque volume and determining plaque composition, including high-risk non-calcified plaque.
HeartFlow Analysis operates on a fee-for-service model and is covered by Medicare and most U.S. commercial payers, with established Category I CPT codes for FFRct Analysis (75580) and AI-Enabled Quantitative Plaque Analysis (75577 for 2026). vascuCAP's pricing information is available upon contact, and specific reimbursement details are not provided in its description.
HeartFlow Analysis includes Fractional Flow Reserve derived from CT (FFRct) analysis and Computational Fluid Dynamics (CFD) for blood flow simulation, providing a functional assessment of how blockages impact blood flow. vascuCAP focuses on plaque composition quantification and characterization, and risk stratification for stroke and heart attack, without explicitly mentioning FFRct or blood flow simulation as a feature.
vascuCAP's plaque quantification and characterization are histologically-validated. HeartFlow Plaque Analysis is an AI-driven plaque analysis prospectively validated with 95% agreement to the invasive gold-standard, intravascular ultrasound (IVUS).